{
  "company": {
    "name": "Agomab Therapeutics",
    "website": "https://agomab.com/",
    "record": "https://startuphistory.org/c/agomab.com"
  },
  "status": null,
  "history_since": "2020-08-23T00:16:52.000Z",
  "baseline": {
    "snapshot_id": "596c65f6f7159e9c126c5d93c62dd15316bd998e111ea6d00c6b178a9b0e55ef",
    "observed_at": "2020-08-23T00:16:52.000Z",
    "headline": null,
    "description": "agonistic antibodies that regenerate damaged tissues",
    "evidence": "https://web.archive.org/web/20200823001652/https://agomab.com/",
    "evidence_kind": "internet_archive",
    "facts": {
      "version": 1,
      "pages": [
        {
          "page": "home",
          "customers": [],
          "investors": [],
          "prices": [],
          "compliance": [],
          "funding": [
            "AgomAb Therapeutics Closes Series A Extension Round with Additional Funding from Andera Partners Oct 10, 2019 AgomAb Therapeutics N.V."
          ]
        }
      ]
    },
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 2,
  "last_checked": "2026-11-06T14:15:24.513Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2025-07-08T08:24:31.000Z",
      "variants": [
        {
          "headline": "AgomAb Therapeutics – Restoring Organ Function",
          "subhead": null,
          "observed_at": "2021-03-11T20:16:56.000Z",
          "evidence": "https://web.archive.org/web/20210311201656/https://agomab.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "AgomAb Therapeutics – Restoring Organ Function",
          "subhead": null,
          "observed_at": "2022-01-12T17:21:41.000Z",
          "evidence": "https://web.archive.org/web/20220112172141/https://agomab.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "AgomAb Therapeutics – Restoring Organ Function",
          "subhead": null,
          "observed_at": "2022-07-13T12:47:06.000Z",
          "evidence": "https://web.archive.org/web/20220713124706/https://agomab.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Agomab Therapeutics – Restoring Organ Function",
          "subhead": null,
          "observed_at": "2023-09-26T08:35:48.000Z",
          "evidence": "https://web.archive.org/web/20230926083548/https://agomab.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Agomab Therapeutics – Restoring Organ Function",
          "subhead": null,
          "observed_at": "2024-01-04T08:04:05.000Z",
          "evidence": "https://web.archive.org/web/20240104080405/https://agomab.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Agomab Therapeutics – Restoring Organ Function",
          "subhead": null,
          "observed_at": "2025-01-08T15:07:34.000Z",
          "evidence": "https://web.archive.org/web/20250108150734/https://agomab.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Agomab Therapeutics – Restoring Organ Function",
          "subhead": null,
          "observed_at": "2025-07-08T08:24:31.000Z",
          "evidence": "https://web.archive.org/web/20250708082431/https://agomab.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Agomab Therapeutics – Restoring Organ Function",
      "subhead": null,
      "from": "2021-03-11T20:16:56.000Z",
      "to": "2025-07-08T08:24:31.000Z",
      "captures": 7,
      "evidence": "https://web.archive.org/web/20250708082431/https://agomab.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2021-03-11T20:16:56.000Z",
          "to": "2025-07-08T08:24:31.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T14:15:24.513Z",
      "variants": [
        {
          "headline": "Agomab Therapeutics – building a company focused on treating fibrosis",
          "subhead": null,
          "observed_at": "2026-02-03T16:35:54.000Z",
          "evidence": "https://web.archive.org/web/20260203163554/https://agomab.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Agomab Therapeutics – building a company focused on treating fibrosis",
          "subhead": null,
          "observed_at": "2026-04-24T11:36:13.000Z",
          "evidence": "https://web.archive.org/web/20260424113613/https://agomab.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Agomab Therapeutics – building a company focused on treating fibrosis",
          "subhead": null,
          "observed_at": "2026-07-12T12:11:25.000Z",
          "evidence": "https://web.archive.org/web/20260712121125/https://agomab.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Agomab Therapeutics – building a company focused on treating fibrosis",
          "subhead": null,
          "observed_at": "2026-10-08T23:57:08.000Z",
          "evidence": "https://web.archive.org/web/20261008235708/https://agomab.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Agomab Therapeutics – building a company focused on treating fibrosis",
          "subhead": null,
          "observed_at": "2026-11-04T09:43:43.699Z",
          "evidence": "https://agomab.com/",
          "evidence_kind": "live_capture"
        },
        {
          "headline": "Agomab Therapeutics – building a company focused on treating fibrosis",
          "subhead": null,
          "observed_at": "2026-11-06T14:15:24.513Z",
          "evidence": "https://agomab.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Agomab Therapeutics – building a company focused on treating fibrosis",
      "subhead": null,
      "from": "2026-02-03T16:35:54.000Z",
      "to": "2026-11-06T14:15:24.513Z",
      "captures": 6,
      "evidence": "https://agomab.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-02-03T16:35:54.000Z",
          "to": "2026-11-06T14:15:24.513Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-596c65f6f7159e9c126c5d93c62dd15316bd998e111ea6d00c6b178a9b0e55ef:6d01e35944f232a243e2996aef8736b655c3174ec49425252950344fc09fb97a:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20200823001652/https://agomab.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2020-08-23T00:16:52.000Z",
        "to": "2021-03-11T20:16:56.000Z"
      },
      "evidence": "https://web.archive.org/web/20210311201656/https://agomab.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    },
    {
      "n": 2,
      "id": "page-d0ac1433b886d905ce25d3fbec488ea89d9969ce01c60bf084aeec060dd63974:446db34c9622d080a7e8760d70e967d59afc460dd419e50cea566fa7a27dde1b:funding:e6c1a9a8bb511b39",
      "before_evidence": "https://web.archive.org/web/20240104080405/https://agomab.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “Under his leadership, CureVac raised over $1.6 billion in equity.”.",
      "between": {
        "from": "2024-01-04T08:04:05.000Z",
        "to": "2025-01-08T15:07:34.000Z"
      },
      "evidence": "https://web.archive.org/web/20250108150734/https://agomab.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 3,
      "id": "page-fc8e22f73621790af80ef3ab0c7df52bc660d053fbb7e30a57e024faa1eeaa1c:8fe10dac295c7454398d247bd3fde6611f52432cf2a4e93843318d88c1ba9d29:headline:aa0b5cd8300ec880",
      "before_evidence": "https://web.archive.org/web/20250708082431/https://agomab.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Agomab Therapeutics – Restoring Organ Function” to “Agomab Therapeutics – building a company focused on treating fibrosis”.",
      "between": {
        "from": "2025-07-08T08:24:31.000Z",
        "to": "2026-02-03T16:35:54.000Z"
      },
      "evidence": "https://web.archive.org/web/20260203163554/https://agomab.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": {
    "headline": "Agomab Therapeutics updates homepage focus and leadership messaging",
    "summary": "Agomab Therapeutics revised its homepage headline to emphasize a focus on treating fibrosis and highlighted leadership experience tied to a substantial equity raise at another company, and it added a careers page.",
    "points": [
      {
        "text": "Between July 2025 and February 2026, Agomab Therapeutics changed its homepage headline from “Agomab Therapeutics – Restoring Organ Function” to “Agomab Therapeutics – building a company focused on treating fibrosis”.",
        "kind": "fact",
        "changes": [
          3
        ]
      },
      {
        "text": "Between January 2024 and January 2025, Agomab Therapeutics’ homepage stated: “Under his leadership, CureVac raised over $1.6 billion in equity.”",
        "kind": "fact",
        "changes": [
          2
        ]
      },
      {
        "text": "Between August 2020 and March 2021, Agomab Therapeutics added a careers page.",
        "kind": "fact",
        "changes": [
          1
        ]
      },
      {
        "text": "The fibrosis-focused homepage headline between July 2025 and February 2026 suggests Agomab Therapeutics may be emphasizing fibrosis as a central theme of its positioning.",
        "kind": "interpretation",
        "changes": [
          3
        ]
      }
    ],
    "written_at": "2026-11-07T21:00:07.792Z",
    "basis": "ai_analysis",
    "model": "gpt-5.1-2025-11-13"
  },
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Agomab Therapeutics” company record, https://startuphistory.org/c/agomab.com"
}